Monika Tomaszewska-Kiecana

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Juvenile Idiopathic Arthritis

Respiratory Syndrome Coronavirus

Top Venues

Expert review of clinical immunology

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Monika Tomaszewska-Kiecana, Martin Ullmann, Corinne Petit-Frere, Joëlle Monnet, Christos Dagres, Andras Illes
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults. Expert review of clinical immunology (2023)
Monika Tomaszewska-Kiecana, Anna Dryja, Martin Ullmann, Corinne Petit-Frere, Andras Illes, Christos Dagres, Joëlle Monnet
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Expert review of clinical immunology (2023)
Monika Tomaszewska-Kiecana, Martin Ullmann, Corinne Petit-Frere, Joëlle Monnet, Christos Dagres, Andras Illes
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults. Expert review of clinical immunology (2023)
Monika Tomaszewska-Kiecana, Anna Dryja, Martin Ullmann, Corinne Petit-Frere, Andras Illes, Christos Dagres, Joëlle Monnet
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Expert review of clinical immunology (2023)
Monika Tomaszewska-Kiecana, Martin Ullmann, Corinne Petit-Frere, Joëlle Monnet, Christos Dagres, Andras Illes
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults. Expert review of clinical immunology (2023)
Ji-Min Seo, Bobin Kang, Rina Song, Hanmi Noh, Cheolmin Kim, Jong-In Kim, Minsoo Kim, Dong-Kyun Ryu, Min-Ho Lee, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Hansaem Lee, Hye-Min Woo, Jun-Won Kim, Jung-Ah Choi, Man Ki Song, Monika Tomaszewska-Kiecana, Anna Wołowik, Agnieszka Kulesza, Sung Hyun Kim, Keum Young Ahn, Nahyun Jung, Soo-Young Lee
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging microbes & infections 11 (1) (2022)